Duopharma Biotech BhdXKLS:7148 +2.48%83 Days Inventory is 178.92 as of Mar. 2026, which is 2% above its 10-year median of 176.06. GuruFocus rates XKLS:7148 with a GF Score™ of 83/100 and a GF Value™ of RM1.53 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 916 Drug Manufacturers companies, Duopharma Biotech Bhd ranks worse than 58.3% on this metric.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Duopharma Biotech Bhd's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.51.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Duopharma Biotech Bhd's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 1.19.
Duopharma Biotech Bhd (XKLS:7148) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Duopharma Biotech Bhd's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Duopharma Biotech Bhd's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Duopharma Biotech Bhd Days Inventory Related Terms
Duopharma Biotech Bhd Days Inventory Historical Data
* Premium members only.
The historical data trend for Duopharma Biotech Bhd's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:7148 vs ZTS, UTHR, VTRS: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Duopharma Biotech Bhd's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Duopharma Biotech Bhd Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Duopharma Biotech Bhd's Days Inventory distribution charts can be found below:
* The bar in red indicates where Duopharma Biotech Bhd's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Duopharma Biotech Bhd (XKLS:7148) has a Days Inventory of 178.92 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Duopharma Biotech Bhd and its competitors. This is near median its historical median of 176.06. Over the past decade, Duopharma Biotech Bhd's Days Inventory has ranged from 150.29 to 262.24. According to the industry distribution chart, Duopharma Biotech Bhd ranks #534 out of 916 companies in the Drug Manufacturers industry, placing it in the top 58.3%.
Is Duopharma Biotech Bhd's Days Inventory too high?
Duopharma Biotech Bhd's current Days Inventory of 178.92 is near median its 10-year median of 176.06. Over the past 10 years, this metric has ranged from a low of 150.29 to a high of 262.24. The Drug Manufacturers industry median Days Inventory is 164.43. Duopharma Biotech Bhd's value of 178.92 is 8.8% above this industry median. Based on the distribution chart, Duopharma Biotech Bhd ranks #534 out of 916 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Duopharma Biotech Bhd has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Duopharma Biotech Bhd's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Duopharma Biotech Bhd ranks #534 out of 916 companies for Days Inventory. This places Duopharma Biotech Bhd in the lower half of its industry. The industry median Days Inventory is 164.43. Duopharma Biotech Bhd's value of 178.92 is 8.8% above this benchmark. Historically, Duopharma Biotech Bhd's own Days Inventory has ranged from 150.29 to 262.24 over the past decade. While the company's 10-year median is 176.06 vs. the industry median of 164.43, Duopharma Biotech Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.43, based on 916 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Duopharma Biotech Bhd's current Days Inventory of 178.92 is 8.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Duopharma Biotech Bhd and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Duopharma Biotech Bhd's current Days Inventory is 178.92, which is near median its own 10-year median of 176.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Duopharma Biotech Bhd stock overvalued right now?
Based on GuruFocus' analysis, Duopharma Biotech Bhd (XKLS:7148) is currently considered Modestly Undervalued. The stock's GF Value™ is RM1.53, compared to a current price of RM1.24 — trading 19% below its estimated fair value. The current Days Inventory is 178.92, which is near median its 10-year median of 176.06 and 8.8% above the Drug Manufacturers industry median of 164.43. Duopharma Biotech Bhd's overall GF Score™ is 83/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Duopharma Biotech Bhd (XKLS:7148), the current Days Inventory is 178.92 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Duopharma Biotech Bhd (XKLS:7148) Overvalued in 2026?
Based on GuruFocus' analysis, Duopharma Biotech Bhd stock appears to be undervalued.
The current stock price of RM1.24 is trading 19% below its estimated GF Value™ of RM1.53.
GuruFocus considers Duopharma Biotech Bhd to be Modestly Undervalued.
Key valuation signals for XKLS:7148:
Days Inventory: 178.92 (near median its 10-year median of 176.06)
GF Value™: RM1.53 vs. price of RM1.24 (19% below fair value)
Industry Position: 8.8% above the Drug Manufacturers median (#534 of 916)
No single metric tells the full story. See the XKLS:7148 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Duopharma Biotech Bhd is an investment holding company engaged in manufacturing pharmaceuticals. The company develops, manufactures, and markets generic and over-the-counter pharmaceutical products. The operating segment of the company is the manufacturing and distribution of pharmaceutical products. The principal activities of its subsidiary are to carry out business as a manufacturer, distributor, importer, and exporter of pharmaceutical products and medicines. Geographically, the company generates the majority of its revenue from Malaysia.
83GF Score
Get the complete analysis for XKLS:7148
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7148 has been successfully added to your 
